The global Prostate-Specific Antigen (PSA) Test market was valued at US$ 511 million in 2023 and is anticipated to reach US$ 628.6 million by 2030, witnessing a CAGR of 2.9% during the forecast period 2024-2030.

Prostate-Specific Antigen (PSA) Test Market

Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), is a glycoprotein enzyme encoded in humans by the KLK3 gene.

The PSA test measures the level of PSA in a man’s blood. For this test, a blood sample is sent to a laboratory for analysis. The results are usually reported as nanograms of PSA per milliliter (ng/mL) of blood.

The major players in global PSA Test market include Abbott, Siemens Healthcare, DiaSorin, etc. The top 3 players occupy about 50% shares of the global market. North America and Europe are main markets, they occupy over 80% of the global market. CLIA is the main type, with a share over 70%. Screening is the key application, which holds a share about 80%.

This report aims to provide a comprehensive presentation of the global market for Prostate-Specific Antigen (PSA) Test, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate-Specific Antigen (PSA) Test.

Report Scope

The Prostate-Specific Antigen (PSA) Test market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prostate-Specific Antigen (PSA) Test market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Prostate-Specific Antigen (PSA) Test companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Prostate-Specific Antigen (PSA) Test Market Report

Report Metric	Details
Report Name	Prostate-Specific Antigen (PSA) Test Market
Accounted market size in 2023	US$ 511 million
Forecasted market size in 2030	US$ 628.6 million
CAGR	2.9%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	CLIA ELISA Other
Segment by Application	Screening Post-treatment Monitoring Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott, Siemens Healthcare, DiaSorin, Roche, Beckman Coulter, PerkinElmer, Tosoh, Ortho Clinical, Fujirebio, Mediwatch (LABORIE), BodiTech
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostate-Specific Antigen (PSA) Test companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Prostate-Specific Antigen (PSA) Test Market growing?

Ans: The Prostate-Specific Antigen (PSA) Test Market witnessing a CAGR of 2.9% during the forecast period 2024-2030.

What is the Prostate-Specific Antigen (PSA) Test Market size in 2030?

Ans: The Prostate-Specific Antigen (PSA) Test Market size in 2030 will be US$ 628.6 million.

What is the market share of major companies in Prostate-Specific Antigen (PSA) Test Market?

Ans: The top 3 players occupy about 50% shares of the global market.

What is the Prostate-Specific Antigen (PSA) Test Market share by type?

Ans: CLIA is the main type, with a share over 70%.

What is the Prostate-Specific Antigen (PSA) Test Market share by application?

Ans: Screening is the key application, which holds a share about 80%.

Who are the main players in the Prostate-Specific Antigen (PSA) Test Market report?

Ans: The main players in the Prostate-Specific Antigen (PSA) Test Market are Abbott, Siemens Healthcare, DiaSorin, Roche, Beckman Coulter, PerkinElmer, Tosoh, Ortho Clinical, Fujirebio, Mediwatch (LABORIE), BodiTech

What are the Application segmentation covered in the Prostate-Specific Antigen (PSA) Test Market report?

Ans: The Applications covered in the Prostate-Specific Antigen (PSA) Test Market report are Screening, Post-treatment Monitoring, Other

What are the Type segmentation covered in the Prostate-Specific Antigen (PSA) Test Market report?

Ans: The Types covered in the Prostate-Specific Antigen (PSA) Test Market report are CLIA, ELISA, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Prostate-Specific Antigen (PSA) Test Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 CLIA

1.2.3 ELISA

1.2.4 Other

1.3 Market by Application

1.3.1 Global Prostate-Specific Antigen (PSA) Test Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Screening

1.3.3 Post-treatment Monitoring

1.3.4 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Prostate-Specific Antigen (PSA) Test Market Perspective (2019-2030)

2.2 Prostate-Specific Antigen (PSA) Test Growth Trends by Region

2.2.1 Global Prostate-Specific Antigen (PSA) Test Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Prostate-Specific Antigen (PSA) Test Historic Market Size by Region (2019-2024)

2.2.3 Prostate-Specific Antigen (PSA) Test Forecasted Market Size by Region (2025-2030)

2.3 Prostate-Specific Antigen (PSA) Test Market Dynamics

2.3.1 Prostate-Specific Antigen (PSA) Test Industry Trends

2.3.2 Prostate-Specific Antigen (PSA) Test Market Drivers

2.3.3 Prostate-Specific Antigen (PSA) Test Market Challenges

2.3.4 Prostate-Specific Antigen (PSA) Test Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Prostate-Specific Antigen (PSA) Test Players by Revenue

3.1.1 Global Top Prostate-Specific Antigen (PSA) Test Players by Revenue (2019-2024)

3.1.2 Global Prostate-Specific Antigen (PSA) Test Revenue Market Share by Players (2019-2024)

3.2 Global Prostate-Specific Antigen (PSA) Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Prostate-Specific Antigen (PSA) Test Revenue

3.4 Global Prostate-Specific Antigen (PSA) Test Market Concentration Ratio

3.4.1 Global Prostate-Specific Antigen (PSA) Test Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Prostate-Specific Antigen (PSA) Test Revenue in 2023

3.5 Prostate-Specific Antigen (PSA) Test Key Players Head office and Area Served

3.6 Key Players Prostate-Specific Antigen (PSA) Test Product Solution and Service

3.7 Date of Enter into Prostate-Specific Antigen (PSA) Test Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Prostate-Specific Antigen (PSA) Test Breakdown Data by Type

4.1 Global Prostate-Specific Antigen (PSA) Test Historic Market Size by Type (2019-2024)

4.2 Global Prostate-Specific Antigen (PSA) Test Forecasted Market Size by Type (2025-2030)

5 Prostate-Specific Antigen (PSA) Test Breakdown Data by Application

5.1 Global Prostate-Specific Antigen (PSA) Test Historic Market Size by Application (2019-2024)

5.2 Global Prostate-Specific Antigen (PSA) Test Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Prostate-Specific Antigen (PSA) Test Market Size (2019-2030)

6.2 North America Prostate-Specific Antigen (PSA) Test Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Prostate-Specific Antigen (PSA) Test Market Size by Country (2019-2024)

6.4 North America Prostate-Specific Antigen (PSA) Test Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Prostate-Specific Antigen (PSA) Test Market Size (2019-2030)

7.2 Europe Prostate-Specific Antigen (PSA) Test Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Prostate-Specific Antigen (PSA) Test Market Size by Country (2019-2024)

7.4 Europe Prostate-Specific Antigen (PSA) Test Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size (2019-2030)

8.2 Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size by Region (2019-2024)

8.4 Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Prostate-Specific Antigen (PSA) Test Market Size (2019-2030)

9.2 Latin America Prostate-Specific Antigen (PSA) Test Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Prostate-Specific Antigen (PSA) Test Market Size by Country (2019-2024)

9.4 Latin America Prostate-Specific Antigen (PSA) Test Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size (2019-2030)

10.2 Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size by Country (2019-2024)

10.4 Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abbott

11.1.1 Abbott Company Detail

11.1.2 Abbott Business Overview

11.1.3 Abbott Prostate-Specific Antigen (PSA) Test Introduction

11.1.4 Abbott Revenue in Prostate-Specific Antigen (PSA) Test Business (2019-2024)

11.1.5 Abbott Recent Development

11.2 Siemens Healthcare

11.2.1 Siemens Healthcare Company Detail

11.2.2 Siemens Healthcare Business Overview

11.2.3 Siemens Healthcare Prostate-Specific Antigen (PSA) Test Introduction

11.2.4 Siemens Healthcare Revenue in Prostate-Specific Antigen (PSA) Test Business (2019-2024)

11.2.5 Siemens Healthcare Recent Development

11.3 DiaSorin

11.3.1 DiaSorin Company Detail

11.3.2 DiaSorin Business Overview

11.3.3 DiaSorin Prostate-Specific Antigen (PSA) Test Introduction

11.3.4 DiaSorin Revenue in Prostate-Specific Antigen (PSA) Test Business (2019-2024)

11.3.5 DiaSorin Recent Development

11.4 Roche

11.4.1 Roche Company Detail

11.4.2 Roche Business Overview

11.4.3 Roche Prostate-Specific Antigen (PSA) Test Introduction

11.4.4 Roche Revenue in Prostate-Specific Antigen (PSA) Test Business (2019-2024)

11.4.5 Roche Recent Development

11.5 Beckman Coulter

11.5.1 Beckman Coulter Company Detail

11.5.2 Beckman Coulter Business Overview

11.5.3 Beckman Coulter Prostate-Specific Antigen (PSA) Test Introduction

11.5.4 Beckman Coulter Revenue in Prostate-Specific Antigen (PSA) Test Business (2019-2024)

11.5.5 Beckman Coulter Recent Development

11.6 PerkinElmer

11.6.1 PerkinElmer Company Detail

11.6.2 PerkinElmer Business Overview

11.6.3 PerkinElmer Prostate-Specific Antigen (PSA) Test Introduction

11.6.4 PerkinElmer Revenue in Prostate-Specific Antigen (PSA) Test Business (2019-2024)

11.6.5 PerkinElmer Recent Development

11.7 Tosoh

11.7.1 Tosoh Company Detail

11.7.2 Tosoh Business Overview

11.7.3 Tosoh Prostate-Specific Antigen (PSA) Test Introduction

11.7.4 Tosoh Revenue in Prostate-Specific Antigen (PSA) Test Business (2019-2024)

11.7.5 Tosoh Recent Development

11.8 Ortho Clinical

11.8.1 Ortho Clinical Company Detail

11.8.2 Ortho Clinical Business Overview

11.8.3 Ortho Clinical Prostate-Specific Antigen (PSA) Test Introduction

11.8.4 Ortho Clinical Revenue in Prostate-Specific Antigen (PSA) Test Business (2019-2024)

11.8.5 Ortho Clinical Recent Development

11.9 Fujirebio

11.9.1 Fujirebio Company Detail

11.9.2 Fujirebio Business Overview

11.9.3 Fujirebio Prostate-Specific Antigen (PSA) Test Introduction

11.9.4 Fujirebio Revenue in Prostate-Specific Antigen (PSA) Test Business (2019-2024)

11.9.5 Fujirebio Recent Development

11.10 Mediwatch (LABORIE)

11.10.1 Mediwatch (LABORIE) Company Detail

11.10.2 Mediwatch (LABORIE) Business Overview

11.10.3 Mediwatch (LABORIE) Prostate-Specific Antigen (PSA) Test Introduction

11.10.4 Mediwatch (LABORIE) Revenue in Prostate-Specific Antigen (PSA) Test Business (2019-2024)

11.10.5 Mediwatch (LABORIE) Recent Development

11.11 BodiTech

11.11.1 BodiTech Company Detail

11.11.2 BodiTech Business Overview

11.11.3 BodiTech Prostate-Specific Antigen (PSA) Test Introduction

11.11.4 BodiTech Revenue in Prostate-Specific Antigen (PSA) Test Business (2019-2024)

11.11.5 BodiTech Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global Prostate-Specific Antigen (PSA) Test Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of CLIA

Table 3. Key Players of ELISA

Table 4. Key Players of Other

Table 5. Global Prostate-Specific Antigen (PSA) Test Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Prostate-Specific Antigen (PSA) Test Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Prostate-Specific Antigen (PSA) Test Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Prostate-Specific Antigen (PSA) Test Market Share by Region (2019-2024)

Table 9. Global Prostate-Specific Antigen (PSA) Test Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Prostate-Specific Antigen (PSA) Test Market Share by Region (2025-2030)

Table 11. Prostate-Specific Antigen (PSA) Test Market Trends

Table 12. Prostate-Specific Antigen (PSA) Test Market Drivers

Table 13. Prostate-Specific Antigen (PSA) Test Market Challenges

Table 14. Prostate-Specific Antigen (PSA) Test Market Restraints

Table 15. Global Prostate-Specific Antigen (PSA) Test Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Prostate-Specific Antigen (PSA) Test Market Share by Players (2019-2024)

Table 17. Global Top Prostate-Specific Antigen (PSA) Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate-Specific Antigen (PSA) Test as of 2023)

Table 18. Ranking of Global Top Prostate-Specific Antigen (PSA) Test Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Prostate-Specific Antigen (PSA) Test Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Prostate-Specific Antigen (PSA) Test Product Solution and Service

Table 22. Date of Enter into Prostate-Specific Antigen (PSA) Test Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Prostate-Specific Antigen (PSA) Test Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Prostate-Specific Antigen (PSA) Test Revenue Market Share by Type (2019-2024)

Table 26. Global Prostate-Specific Antigen (PSA) Test Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Prostate-Specific Antigen (PSA) Test Revenue Market Share by Type (2025-2030)

Table 28. Global Prostate-Specific Antigen (PSA) Test Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Prostate-Specific Antigen (PSA) Test Revenue Market Share by Application (2019-2024)

Table 30. Global Prostate-Specific Antigen (PSA) Test Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Prostate-Specific Antigen (PSA) Test Revenue Market Share by Application (2025-2030)

Table 32. North America Prostate-Specific Antigen (PSA) Test Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Prostate-Specific Antigen (PSA) Test Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Prostate-Specific Antigen (PSA) Test Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Prostate-Specific Antigen (PSA) Test Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Prostate-Specific Antigen (PSA) Test Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Prostate-Specific Antigen (PSA) Test Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Prostate-Specific Antigen (PSA) Test Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Prostate-Specific Antigen (PSA) Test Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Prostate-Specific Antigen (PSA) Test Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size by Country (2025-2030) & (US$ Million)

Table 47. Abbott Company Detail

Table 48. Abbott Business Overview

Table 49. Abbott Prostate-Specific Antigen (PSA) Test Product

Table 50. Abbott Revenue in Prostate-Specific Antigen (PSA) Test Business (2019-2024) & (US$ Million)

Table 51. Abbott Recent Development

Table 52. Siemens Healthcare Company Detail

Table 53. Siemens Healthcare Business Overview

Table 54. Siemens Healthcare Prostate-Specific Antigen (PSA) Test Product

Table 55. Siemens Healthcare Revenue in Prostate-Specific Antigen (PSA) Test Business (2019-2024) & (US$ Million)

Table 56. Siemens Healthcare Recent Development

Table 57. DiaSorin Company Detail

Table 58. DiaSorin Business Overview

Table 59. DiaSorin Prostate-Specific Antigen (PSA) Test Product

Table 60. DiaSorin Revenue in Prostate-Specific Antigen (PSA) Test Business (2019-2024) & (US$ Million)

Table 61. DiaSorin Recent Development

Table 62. Roche Company Detail

Table 63. Roche Business Overview

Table 64. Roche Prostate-Specific Antigen (PSA) Test Product

Table 65. Roche Revenue in Prostate-Specific Antigen (PSA) Test Business (2019-2024) & (US$ Million)

Table 66. Roche Recent Development

Table 67. Beckman Coulter Company Detail

Table 68. Beckman Coulter Business Overview

Table 69. Beckman Coulter Prostate-Specific Antigen (PSA) Test Product

Table 70. Beckman Coulter Revenue in Prostate-Specific Antigen (PSA) Test Business (2019-2024) & (US$ Million)

Table 71. Beckman Coulter Recent Development

Table 72. PerkinElmer Company Detail

Table 73. PerkinElmer Business Overview

Table 74. PerkinElmer Prostate-Specific Antigen (PSA) Test Product

Table 75. PerkinElmer Revenue in Prostate-Specific Antigen (PSA) Test Business (2019-2024) & (US$ Million)

Table 76. PerkinElmer Recent Development

Table 77. Tosoh Company Detail

Table 78. Tosoh Business Overview

Table 79. Tosoh Prostate-Specific Antigen (PSA) Test Product

Table 80. Tosoh Revenue in Prostate-Specific Antigen (PSA) Test Business (2019-2024) & (US$ Million)

Table 81. Tosoh Recent Development

Table 82. Ortho Clinical Company Detail

Table 83. Ortho Clinical Business Overview

Table 84. Ortho Clinical Prostate-Specific Antigen (PSA) Test Product

Table 85. Ortho Clinical Revenue in Prostate-Specific Antigen (PSA) Test Business (2019-2024) & (US$ Million)

Table 86. Ortho Clinical Recent Development

Table 87. Fujirebio Company Detail

Table 88. Fujirebio Business Overview

Table 89. Fujirebio Prostate-Specific Antigen (PSA) Test Product

Table 90. Fujirebio Revenue in Prostate-Specific Antigen (PSA) Test Business (2019-2024) & (US$ Million)

Table 91. Fujirebio Recent Development

Table 92. Mediwatch (LABORIE) Company Detail

Table 93. Mediwatch (LABORIE) Business Overview

Table 94. Mediwatch (LABORIE) Prostate-Specific Antigen (PSA) Test Product

Table 95. Mediwatch (LABORIE) Revenue in Prostate-Specific Antigen (PSA) Test Business (2019-2024) & (US$ Million)

Table 96. Mediwatch (LABORIE) Recent Development

Table 97. BodiTech Company Detail

Table 98. BodiTech Business Overview

Table 99. BodiTech Prostate-Specific Antigen (PSA) Test Product

Table 100. BodiTech Revenue in Prostate-Specific Antigen (PSA) Test Business (2019-2024) & (US$ Million)

Table 101. BodiTech Recent Development

Table 102. Research Programs/Design for This Report

Table 103. Key Data Information from Secondary Sources

Table 104. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Prostate-Specific Antigen (PSA) Test Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Prostate-Specific Antigen (PSA) Test Market Share by Type: 2023 VS 2030

Figure 3. CLIA Features

Figure 4. ELISA Features

Figure 5. Other Features

Figure 6. Global Prostate-Specific Antigen (PSA) Test Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Prostate-Specific Antigen (PSA) Test Market Share by Application: 2023 VS 2030

Figure 8. Screening Case Studies

Figure 9. Post-treatment Monitoring Case Studies

Figure 10. Other Case Studies

Figure 11. Prostate-Specific Antigen (PSA) Test Report Years Considered

Figure 12. Global Prostate-Specific Antigen (PSA) Test Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Prostate-Specific Antigen (PSA) Test Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Prostate-Specific Antigen (PSA) Test Market Share by Region: 2023 VS 2030

Figure 15. Global Prostate-Specific Antigen (PSA) Test Market Share by Players in 2023

Figure 16. Global Top Prostate-Specific Antigen (PSA) Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate-Specific Antigen (PSA) Test as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Prostate-Specific Antigen (PSA) Test Revenue in 2023

Figure 18. North America Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Prostate-Specific Antigen (PSA) Test Market Share by Country (2019-2030)

Figure 20. United States Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Prostate-Specific Antigen (PSA) Test Market Share by Country (2019-2030)

Figure 24. Germany Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Prostate-Specific Antigen (PSA) Test Market Share by Region (2019-2030)

Figure 32. China Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Prostate-Specific Antigen (PSA) Test Market Share by Country (2019-2030)

Figure 40. Mexico Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Prostate-Specific Antigen (PSA) Test Market Share by Country (2019-2030)

Figure 44. Turkey Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Prostate-Specific Antigen (PSA) Test Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Abbott Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2019-2024)

Figure 47. Siemens Healthcare Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2019-2024)

Figure 48. DiaSorin Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2019-2024)

Figure 49. Roche Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2019-2024)

Figure 50. Beckman Coulter Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2019-2024)

Figure 51. PerkinElmer Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2019-2024)

Figure 52. Tosoh Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2019-2024)

Figure 53. Ortho Clinical Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2019-2024)

Figure 54. Fujirebio Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2019-2024)

Figure 55. Mediwatch (LABORIE) Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2019-2024)

Figure 56. BodiTech Revenue Growth Rate in Prostate-Specific Antigen (PSA) Test Business (2019-2024)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions